Literature DB >> 27162048

Kidney cancer: Exosome transmission of sunitinib resistance.

Louise Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27162048     DOI： 10.1038/nrurol.2016.88

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.

Authors:  Le Qu; Jin Ding; Cheng Chen; Zhen-Jie Wu; Bing Liu; Yi Gao; Wei Chen; Feng Liu; Wen Sun; Xiao-Feng Li; Xue Wang; Yue Wang; Zhen-Yu Xu; Li Gao; Qing Yang; Bin Xu; Yao-Ming Li; Zi-Yu Fang; Zhi-Peng Xu; Yi Bao; Deng-Shuang Wu; Xiong Miao; Hai-Yang Sun; Ying-Hao Sun; Hong-Yang Wang; Lin-Hui Wang
Journal:  Cancer Cell       Date:  2016-04-21       Impact factor: 31.743
  1 in total
  7 in total

Review 1.  Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Authors:  Jessie L-S Au; Roberto A Abbiati; M Guillaume Wientjes; Ze Lu
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

2.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

3.  Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.

Authors:  Jin Wang; Bertrand Z Yeung; Minjian Cui; Cody J Peer; Ze Lu; William D Figg; M Guillaume Wientjes; Sukyung Woo; Jessie L-S Au
Journal:  J Control Release       Date:  2017-10-18       Impact factor: 9.776

Review 4.  Potential Applications of Nanotechnology in Urological Cancer.

Authors:  Ming-Hui He; Li Chen; Ting Zheng; Yu Tu; Qian He; Hua-Lin Fu; Ju-Chun Lin; Wei Zhang; Gang Shu; Lili He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2018-07-09       Impact factor: 5.810

5.  Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.

Authors:  Mingli Han; Jianguo Hu; Pengwei Lu; Hui Cao; Chao Yu; Xiangke Li; Xueke Qian; Xue Yang; Yunqing Yang; Na Han; Dongwei Dou; Fan Zhang; Mulin Ye; Changcheng Yang; Yuanting Gu; Huaying Dong
Journal:  Cell Death Dis       Date:  2020-01-22       Impact factor: 8.469

Review 6.  Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer.

Authors:  Ancuta Jurj; Cecilia Pop-Bica; Ondrej Slaby; Cristina D Ştefan; William C Cho; Schuyler S Korban; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2020-10-17       Impact factor: 5.923

7.  A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy.

Authors:  Jin Wang; Bertrand Z Yeung; M Guillaume Wientjes; Minjian Cui; Cody J Peer; Ze Lu; William D Figg; Sukyung Woo; Jessie L-S Au
Journal:  Pharmaceutics       Date:  2021-06-30       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.